Skip to main content
. 2021 May 25;10(3):130–136. doi: 10.5501/wjv.v10.i3.130

Table 1.

Description and outcome of the studied patients


Case 1
Case 2
Case 3
Age 43 50 47
BMI (kg/m2) 27.4 24.7 27.1
Creatinine (micromole/L) 97 64 81
EF% 62 57 58
Additive European score 0.68% 0.8% 0.68%
CPB time (min) 86 75 85
ACC time (min) 43 30 48
Anesthesia time (min) 287 280 245
VIS 13 5 8
LOSICU (h) 49 22 18
LOV (min) 707 722 505
LOShosp (d) 18 18 22
POAF None None None
AKI None None None
In-hospital-mortality None None None
VA-ECMO None None None
Re-admission ICU None None None
Re-exploration None None None
PMI None None None
Pulmonary complications None None None
Thromoembolic complications None None None
Post-operative CXR requirement None None None

ACC: Aortic cross clamp; AKI: Acute kidney injury; BMI: Body mass index; CXR: Chest X-ray; CPB: Cardiopulmonary bypass; EF: Ejection fraction; LOSICU: Length of stay in intensive care unit; LOV: Length of mechanical ventilation; LOShosp: Hospital length of stay; PMI: Perioperative myocardial infarction; POAF: Post-operative atrial fibrillation; VA-ECMO: Venoarterial extracorporeal membrane oxygenation; VIS: Vasoactive inotrope score; ICU: Intensive care unit.